The evidence field · updated daily
7,730
peptide studies,
read so you don't have to.
Every randomized trial, cohort, review and preclinical paper on the peptides people actually use — pulled from 5 primary sources, distilled into a plain-English digest, tagged by evidence strength, and laid out below as a living map of the field.
4,182 studies dated 2026 alone — the peptide literature is compounding.
Where it comes from
- PubMed 4,789
- ClinicalTrials.gov 2,429
- EuropePMC 351
- DailyMed 131
- PubChem 30
Evidence strength
- Strong · trials & meta-analyses 461
- Moderate · cohorts & reviews 251
- Early · preclinical & in-vitro 988
-
68Ga-FAPI-04 PET/CT detects peritoneal fibrosis in mice and correlates with functional decline in dialysis patients
68Ga-FAPI-04 PET/CT accurately identified peritoneal fibrosis in a mouse model and inversely correlated with Kt/V in dialysis patients, suggesting a non-invasive diagnostic tool.
-
Review Unravels Bidirectional Mitophagy-Pyroptosis Axis as Key Regulator of Cell Fate and Inflammation
Understanding the **mitophagy-pyroptosis axis** offers a transformative paradigm for precision therapy, moving beyond single-target interventions. This review highlights that modulating this intricate network, potentially with natural sm…
-
Aptamer-targeted CRISPR **MDM2 knockout** induces cell cycle arrest and TAp73 in patient cancer cells, p53-independent.
An aptamer-targeted CRISPR platform for **MDM2 knockout** effectively induces cell cycle arrest and upregulates anti-tumor TAp73 in patient-derived cancer cells, irrespective of their p53 status.
-
Review highlights advances in cell-permeable nanobodies for intracellular targeting and therapeutic applications
This review is crucial for researchers and developers, as it consolidates the diverse strategies for **intracellular nanobody delivery**, accelerating the development of novel therapeutics. **For peptide users and biohackers, understandi…
-
Paeonol attenuates UVB-induced premature senescence in human dermal fibroblasts, reducing ROS, p16/p21, MMP-1, and SASP.
Paeonol reduced UVB-induced premature senescence in human dermal fibroblasts, decreasing SA-β-gal, ROS, p16/p21, MMP-1, and SASP factors, suggesting skin longevity benefits.
-
Excessive Oral Water Intake During Labor Causes Severe Maternal and Neonatal Hyponatremia
This case report significantly impacts clinical practice by highlighting that **excessive oral water intake during labor is a standalone risk factor for severe maternal and neonatal hyponatraemia**. For clinicians, this means heightened …
-
Oxytocin receptor antagonism shows investigational promise for lower urinary tract symptoms, requiring clinical validation.
Oxytocin receptor (OXTR) antagonism is investigational for lower urinary tract symptoms (LUTS) and overactive bladder (OAB), showing preclinical promise but needing clinical validation due to species differences and cross-reactivity.
-
Carbetocin for vaginal delivery PPH prophylaxis shows no significant adjusted blood loss difference versus oxytocin.
Carbetocin recipients for postpartum hemorrhage prophylaxis after vaginal delivery showed no significant adjusted blood loss difference compared to oxytocin.
-
Review Highlights Semaglutide, Liraglutide, and Phentermine/Topiramate as Effective Pharmacotherapies for Child and Adolescent Obesity
Intensive family-based behavioral treatment is foundational for child and adolescent obesity; semaglutide and liraglutide add further BMI reduction.
-
Oral Citrulline Study Aims to Enhance Protein Synthesis in Intestinal Failure Patients
A study aims to determine if oral citrulline enhances whole-body protein synthesis in patients with intestinal failure, hypothesizing decreased leucine oxidation and stimulated synthesis.
-
New intravenous medication combination explored for improving post-stroke motor function in open-label study
While specific findings are not yet available, this **open-label study represents an early exploration into new therapeutic avenues for stroke recovery**. If the ongoing evaluations yield positive results, a novel intravenous medication …
-
Prophylactic Tranexamic Acid Safely Reduces Postpartum Hemorrhage in High-Risk Cesarean Deliveries
Prophylactic **tranexamic acid** (TXA) safely reduces postpartum hemorrhage and associated risks in high-risk women with systemic autoimmune diseases undergoing cesarean delivery.
-
Dietitian-led 'Healthy Conversations' protocol aims to optimize gestational weight gain and maternal-infant outcomes
A randomized controlled trial protocol investigates if dietitian-led 'Healthy Conversations' improve gestational weight gain and maternal-infant outcomes in pregnant women.
-
Intranasal Oxytocin's Impact on Deception: A Study to Explore Lying and Lie Detection
Understanding how **oxytocin** influences deception could have significant implications for various fields, from psychology and neuroscience to law enforcement and clinical interventions. If oxytocin is found to modulate lying or lie det…
-
Intramuscular Oxytocin Investigated for Modulation of Autonomic Nervous System Activity in Healthy Individuals
Without reported findings, the direct implications for peptide users, biohackers, or clinicians cannot be determined. This study's design aims to explore a fundamental aspect of oxytocin's physiological effects on the autonomic nervous s…
-
Randomized trial to assess **electrical-acupuncture** or **TENS** for early postpartum breast engorgement
A randomized controlled trial will evaluate **electrical-acupuncture** or **TENS** as add-on treatments for early postpartum breast engorgement in 36 women.
-
Sublingual Misoprostol Reduces Blood Loss During Elective Cesarean Delivery in Randomized Controlled Trial
Sublingual misoprostol was investigated for its potential to reduce blood loss during elective cesarean delivery in a randomized controlled trial.
-
Engineered M13 Bacteriophage Detects Salmonella with Dual Colorimetric and SERS Signals, Achieving Sub-4 CFU/mL LODs
This dual-modal M13 bacteriophage assay represents a significant step forward for **rapid, on-site food safety testing**, potentially reducing the time required to detect Salmonella from days to hours. For food producers and regulatory b…
-
Ferula communis Extract (FER-E) Dose- and Time-Dependently Modulates Bone Remodeling in Osteosarcoma Cells
Ferula communis extract (FER-E) modulated bone remodeling in human osteosarcoma cells, preserving osteoblastic activity in a dose- and time-dependent manner.
-
Multifunctional Anti-HIV-1 HSPC Gene Therapy with Negative Selection Marker Shows Feasibility and Safety in Pigtail Macaques
Autologous HSPC gene therapy, delivering anti-HIV-1 payloads via lentiviral vector, achieved safe hematopoietic recovery and sustained multilineage gene marking in pigtail macaques; modified cells expanded upon SHIV challenge.
-
Neuromedin B regulates porcine granulosa cell proliferation, apoptosis, and steroidogenesis via NMBR
Neuromedin B (NMB) differentially regulates porcine ovarian granulosa cell function, increasing viability and E2 production while reducing apoptosis via the NMBR.
-
Therapeutic E. coli T4 and Staph A5/80 phages induce mild monocyte-driven cytokine response
Phages T4 and A5/80 induced a mild, monocyte-driven cytokine response in human PBMCs, significantly less than adenovirus, suggesting a limited inflammatory footprint for therapeutic phages.
-
Bungarus multicinctus Venom Triggers Microglial Pyroptosis via NLRP3/Caspase-1/GSDMD Pathway
This study provides crucial insights into the cellular mechanisms underlying **Bungarus multicinctus venom** toxicity, specifically its ability to induce microglial pyroptosis and neuroinflammation. **Identifying the `NLRP3/Caspase-1/GSD…
-
Plecanatide 3 mg dose offers optimal balance for chronic constipation and IBS-C, boosting bowel movements
Plecanatide significantly increased complete spontaneous bowel movements (CSBMs) across all doses in chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), with the **3 mg** dose demonstrating the b…
-
Dried blood spot IP-10 predicts tuberculosis severity and treatment response, showing earlier decline with good outcomes
Interferon-γ-inducible protein 10 (IP-10) in dried blood spots correlated with **tuberculosis** severity and predicted treatment response, with earlier declines observed in patients with good clinical outcomes.
-
Review highlights state-of-the-art RPLC methods for therapeutic oligonucleotide and peptide-conjugate analysis
**Optimized RPLC methods are crucial for advancing peptide-oligonucleotide conjugate (POC) therapeutics**, ensuring their purity and structural integrity. For researchers and developers, this review provides a roadmap for selecting appro…
-
Tirzepatide's Pancreatic and Gallbladder Safety Profile in Obesity Management Systematically Mapped Across Diverse Evidence
A scoping review systematically mapped **tirzepatide**'s pancreatic and gallbladder adverse events in obesity management across 11 RCTs, 5 observational studies, 4 case reports, and pharmacovigilance data.
-
Mazdutide, a Dual GLP-1R/GCGR Agonist, Shows Effectiveness in Glycogen Storage Disease IXc
This case report provides initial evidence that **Mazdutide could offer a therapeutic option for the severe liver complications of GSD IXc**, a condition currently lacking targeted treatments. For clinicians, this suggests exploring dual…
-
Real-World Study Compares Semaglutide and Liraglutide Effectiveness, Adherence, and Safety in Omani Patients
A retrospective study in Omani patients evaluated the real-world effectiveness, adverse events, and adherence of semaglutide and liraglutide for type 2 diabetes and obesity.
-
Sequential Kidney-Protective Therapy Achieved CKD Remission in T2DM Patient Based on eGFR Slope Criterion
**This case report suggests that achieving clinical remission of CKD in T2DM patients may be possible with a sequential, multi-drug approach.** For clinicians, it reinforces the value of combining established kidney-protective therapies …
-
Metabolomics and Lipidomics Reveal Systemic Metabolic Remodeling in Growth Hormone Deficiency
While specific findings are not detailed here, a study leveraging metabolomics and lipidomics in **Growth Hormone Deficiency (GHD)** holds significant promise. **Uncovering the precise systemic metabolic remodeling could lead to novel di…
-
Serum MOTS-c strongly correlated with VO2max and antioxidant markers in healthy young males
This study provides compelling evidence that **MOTS-c** is a significant biomarker for exercise capacity and antioxidant status in young males. For peptide users and biohackers, this suggests that interventions aimed at optimizing **MOTS…
-
Review synthesizes Resistant Starch's impact on MASLD, highlighting microbial ecology and response variability for precision nutrition.
**Understanding the variability in how individuals respond to Resistant Starch (RS) is crucial for MASLD management.** For peptide users and biohackers, this review suggests that simply adding RS may not yield consistent benefits without…
-
Narrative Review Explores Semaglutide and GLP-1RA Link to Papillary Thyroid Carcinoma Risk
Understanding the potential link between GLP-1RAs and **papillary thyroid carcinoma** is crucial for both prescribers and patients. While the existing boxed warning for medullary thyroid carcinoma (MTC) is based on rodent data, this revi…
-
Tirzepatide and Semaglutide Pharmacotherapy Induces Variable Body Composition Changes in Real-World Obesity Patients
Understanding the specific body compartments lost during obesity pharmacotherapy is crucial for optimizing treatment strategies beyond total weight reduction. **Monitoring fat mass versus muscle mass is essential for preserving metabolic…
-
Special Issue explores molecular therapies for diabetes complications, linking metabolic dysfunction to cardiovascular and renal organ protection
This editorial underscores a critical paradigm shift in **diabetes** management: moving beyond mere glucose control to comprehensive organ protection via molecular therapies. **For peptide users and clinicians, this means recognizing tha…
-
Bariatric Surgery's Gut Microbiota–Epigenome Axis Unveiled as Key to Sustained Metabolic Improvement
This review significantly advances our understanding of why **bariatric surgery** yields such durable metabolic benefits, moving beyond simple caloric restriction to a complex interplay of host-microbe interactions. **For clinicians and …
-
Review Interprets Retatrutide's Tri-Agonist Mechanism and Phase 3 Efficacy for Obesity and Diabetes
This review synthesizes emerging Phase 3 data, highlighting **Retatrutide**'s unimolecular GIP/GLP-1/glucagon tri-agonism for superior weight loss and metabolic improvements in obesity and T2D.
-
Review details pharmacodynamics of novel anti-obesity drugs, including GLP-1/GIP agonists and oral semaglutide
The landscape of **obesity** management is rapidly evolving, with a clear shift towards more effective pharmacotherapies that target the underlying neuroendocrine dysregulation. **This review provides a critical overview for clinicians a…
-
HTD1801 (Berberine Ursodeoxycholate) shows potential as comprehensive therapy for MASLD/MASH and CKM syndrome
This review underscores the need for a holistic approach to **MASLD/MASH** within the **CKM syndrome** framework, moving beyond liver-centric treatments. **HTD1801** (Berberine Ursodeoxycholate) emerges as a compelling candidate for a si…
-
Aesthetic Peptide Review Classifies Agents by Fibroblast Mechanisms, Delivery, and Clinical Evidence
**For practitioners and biohackers, this review clarifies that "peptide" is not a monolithic category in aesthetics; specific molecular identity, delivery, and evidence are paramount.** Understanding these distinctions is critical for se…
-
Stable Gastric Pentadecapeptide BPC 157 Demonstrates Broad Cytoprotective Potential in Liver Therapy Review
**BPC 157**'s demonstrated broad-spectrum cytoprotective effects in liver injury models suggest it could offer a more comprehensive therapeutic strategy than many current single-target agents. For peptide users and biohackers, this revie…
-
LL-37/Verteporfin GH-L-VP@PDA hydrogel targets YAP-mediated fibrosis for regenerative infected wound repair.
LL-37 and verteporfin-loaded GH-L-VP@PDA hydrogel promotes regenerative healing in infected wounds by regulating infection, inflammation, and YAP-mediated fibrosis.
-
Protocol Outlines Brief Emotion Focused Therapy for Preschoolers with Anxiety Disorders, Assessing Psychopathology and Biomarkers
If this brief emotion-focused therapy proves effective, it could offer a **significantly more accessible and targeted intervention** for young children with anxiety, potentially improving long-term developmental and mental health outcome…
-
Liraglutide's Cardiac Function and Structure Effects in Type 2 Diabetes Under Randomized Investigation
An 18-week randomized trial is assessing liraglutide's impact on left ventricular function and functional reserve in young adults with Type 2 Diabetes.
-
Research Highlights Critical Gap for Liraglutide and Metformin Combination Studies in Obese PCOS Women with Infertility
Current research identifies a significant gap in studies on **Liraglutide** and **Metformin** combination therapy for weight loss, metabolic parameters, and pregnancy rates in obese women with **PCOS** and infertility, highlighting an ur…
-
Liraglutide trial investigates endothelial function, microvascular blood flow in Type 2 Diabetes Mellitus
A Phase IV clinical trial is evaluating if **Liraglutide** improves **endothelial function** and **microvascular blood flow** in **44** patients with **Type 2 Diabetes Mellitus**.
-
Randomized Trial Compares Employer Weight Management Program With and Without Medication for Obesity
This study could provide crucial real-world evidence for optimizing **employer-based weight management programs**. If combining medication with a structured program proves significantly more effective, it could establish a new standard o…
-
Oral semaglutide trial investigates effects on alcohol craving and consumption in adults with AUD
If successful, this trial could establish **oral semaglutide as a novel, well-tolerated therapeutic option for Alcohol Use Disorder (AUD)**, addressing a significant unmet medical need. Its established safety profile for metabolic condit…
-
Trial to Evaluate Endoscopic Duodenal PEF Therapy with Semaglutide for Insulin-Dependent Type 2 Diabetes
**If successful, this combined therapeutic strategy could represent a novel, potentially disease-modifying approach for individuals with insulin-dependent Type 2 Diabetes.** It signifies a shift beyond purely pharmacological management b…
-
Tirzepatide 7.5 mg SC to be assessed for increasing esophageal acid exposure time in adults with obesity
Single **tirzepatide 7.5 mg** SC dose to be assessed for increasing esophageal acid exposure time over 96 hours in adults with obesity.
-
Dual and Triple Agonists Transform MASLD Therapy by Targeting Multiple Incretin and Metabolic Pathways
Dual and triple agonists like **Tirzepatide** and **Retatrutide** are transforming **MASLD** therapy, achieving significant reductions in liver fat and body weight via multi-incretin targeting.
-
Oxytocin and Placebo Nasal Spray Investigate Expectation-Driven Modulation of Empathic Pain
**Understanding the interplay of belief, expectation, and oxytocin in modulating empathic pain could offer novel non-pharmacological and pharmacological strategies for individuals susceptible to vicarious trauma or compassion fatigue.** …
-
Review finds incretin and nutrient-sensing GPCR therapeutic failures in T2D often due to modality, not target biology
This review fundamentally shifts the focus for **type 2 diabetes** drug development from merely identifying novel targets to optimizing drug modality and formulation. For biohackers and clinicians, this implies that the *delivery method*…
-
SGLT2i and GLP-1 RA prescribing for guideline-eligible T2D patients increased 11.4% after 2019 ADA update
Guideline-targeted SGLT2i and GLP-1 RA prescribing for type 2 diabetes patients increased **11.4 percentage points** from 2018-2022 after the 2019 ADA update.
-
GLP-1 RA utilization in Medicare beneficiaries with type 2 diabetes and cancer surged from 0.5% to 8.2%
GLP-1 RA use among Medicare beneficiaries with type 2 diabetes and cancer increased from **0.5%** to **8.2%** between 2010 and 2021, a retrospective cohort study found.
-
SGLT2i and GLP1RA show no differential risk for diabetic retinopathy in T2D patients with CKD stages 3-4.
SGLT2 inhibitors and GLP-1 receptor agonists demonstrated no significant difference in incident nonproliferative diabetic retinopathy or progression in T2D patients with CKD stages 3-4.
-
Semaglutide linked to 18% lower mortality, 9% fewer hospitalizations vs. dulaglutide in hemodialysis patients
Semaglutide reduced mortality by **18%** and all-cause hospitalization by **9%** compared to dulaglutide in **3,200** hemodialysis patients with diabetes.
-
Semaglutide cut BMI more than liraglutide in Omani adults with T2DM or obesity
Semaglutide demonstrated superior BMI reduction compared to liraglutide at 3 and 6 months in Omani adults with type 2 diabetes or obesity.
-
GLP-1 receptor agonist users in Saudi Arabia show suboptimal knowledge and attitudes despite favorable practices
A cross-sectional study of **310** GLP-1 receptor agonist users in Saudi Arabia found only **25.8%** had good knowledge and **33.2%** positive attitudes, contrasting with **54.8%** reporting good practices.
-
Tirzepatide showed greater 3-month real-world weight loss than semaglutide in adults with obesity
Tirzepatide led to significantly greater weight loss than semaglutide at month 3 (-11.52% vs -8.38%, **p < 0.001**) in a real-world cohort of adults with obesity.
-
Retatrutide Unimolecular GIP/GLP-1/Glucagon Tri-Agonist Shows Significant Weight Loss and Glycemic Efficacy in Phase 3 Trials
Retatrutide, a GIP/GLP-1/glucagon tri-agonist, achieved mean weight reductions of **28.3%** (80 weeks) and **28.7%** (68 weeks) in Phase 3 obesity trials, plus glycemic efficacy in T2D.
-
Narrative Review Synthesizes Evidence on GLP-1 Receptor Agonists' Safety, Efficacy, and Neuroprotective Potential in Multiple Sclerosis
**This review provides a crucial synthesis for clinicians managing Multiple Sclerosis (MS) patients, especially those with metabolic comorbidities.** It clarifies the current understanding of GLP-1RAs' safety and efficacy in this populat…
-
Combined Umbilical Cord MSC and Liraglutide Therapy Hypothesized to Improve Type 2 Diabetes Outcomes
**Liraglutide** and umbilical cord mesenchymal stem cells are hypothesized to improve **type 2 diabetes** by enhancing beta-cell function and survival for better glucose control.
-
Semaglutide and Dapagliflozin Combination Trial Compares Renal Outcomes in Obese Kidney Disease Patients
A non-blinded RCT is comparing semaglutide and dapagliflozin, alone and combined, for changes in 24-hour urinary protein and renal function in obese patients with kidney disease.
-
Planned Study to Evaluate Finerenone + Semaglutide for Albuminuria in Non-Diabetic Obese CKD
A multicenter RCT will assess if finerenone combined with semaglutide further reduces albuminuria in non-diabetic obese patients with CKD over 24 weeks.
-
GLP-1 receptor agonist exposure cut postmastectomy lymphedema risk by 62.7% in breast cancer survivors
GLP-1 receptor agonist exposure significantly reduced the incidence of postmastectomy lymphedema by **62.7%** (HR **0.373**, **p < 0.001**) in a large cohort of breast cancer survivors.
-
MOTS-c attenuates placental vascular endothelial cell apoptosis in ICP by inhibiting K33-linked deubiquitination of BACH1
MOTS-c significantly reduced placental vascular endothelial cell apoptosis and improved fetal outcomes in a murine ICP model by promoting BACH1 degradation.
-
CagriSema 2.4 mg yields incremental body weight reduction over semaglutide in Type 2 diabetes.
CagriSema 2.4 mg significantly reduced HbA1c by **-1.87%** and body weight by **-12.69%** vs. placebo, demonstrating probable additional body-weight reduction over semaglutide.
-
Semaglutide exposure during preconception and pregnancy surged in 2023, now leading anti-obesity medications in US claims data.
**The rapid increase in semaglutide exposure during preconception and pregnancy necessitates urgent research into maternal and fetal outcomes.** This finding highlights a critical public health concern for clinicians, pharmacists, and wo…
-
UBT251, a novel triple agonist, significantly reduced HbA1c and weight more than semaglutide in T2DM
**UBT251** represents a significant advancement in the treatment of **type 2 diabetes** and **obesity**, offering superior glycemic control and weight reduction compared to existing GLP-1R agonists like semaglutide. For individuals strug…
-
Subcutaneous Semaglutide Significantly Reduces Atrial Fibrillation Risk Compared to Placebo and Tirzepatide
Subcutaneous **semaglutide** significantly reduced new-onset **atrial fibrillation** risk (RR **0.82** vs placebo; RR **0.57** vs tirzepatide) in a network meta-analysis.
-
Purified Aflatoxin B1 Does Not Impair Broiler Growth but Elicits Subclinical Hepatic, Jejunal, and Renal Responses
Purified Aflatoxin B1 (AFB1) did not affect broiler growth over 42 days but induced subclinical changes in hepatic antioxidant enzymes, jejunal villus height, and renal tubules at various exposure levels.
-
4H30, a 4-branched defensin peptide, exhibits dual virucidal and endosomal trapping activity against human adenoviruses in organoids and hamsters.
**4H30**, a defensin peptide, showed dual virucidal and endosomal trapping against adenoviruses, reducing viral replication in respiratory organoids and hamsters.
-
Once-daily insulin regimens cut district nurse visits 77%, improved HbA1c 1.5% in T2DM.
**Simplifying insulin regimens to once daily can significantly reduce the workload on district nursing teams and improve patient outcomes.** This approach offers a practical solution to the increasing demand for home healthcare, freeing …
-
M1 macrophage membrane-coated gold nanoclusters (TA@CMVs-M1M) precisely target and alleviate acute lung injury
M1 macrophage membrane-coated gold nanoclusters (TA@CMVs-M1M) significantly improved lung accumulation and therapeutic outcomes in LPS-induced ALI mice, demonstrating superior anti-inflammatory effects.
-
Tiplaxtinin inhibits SERPINE1 to suppress circEPSTI1 and reduce dengue virus replication
Tiplaxtinin inhibits `SERPINE1`, reducing `circEPSTI1` expression and suppressing dengue virus replication by targeting the `circEPSTI1-miR-942-5p-SERPINE1-AKT1` axis.
-
Oxytocin's Emerging Role in Preventing Acute Surgical Stress: A Readiness Assessment
This paper evaluates the current evidence and clinical readiness of oxytocin as a prophylactic intervention for acute stress in operating room settings, considering ongoing and future trials.
-
Review Highlights Semaglutide's Emerging Antiarrhythmic Potential in Atrial Fibrillation for High-Risk Patients
**Semaglutide** could offer a transformative, disease-modifying strategy for **atrial fibrillation (AF)**, especially for patients with metabolic comorbidities like **T2D** and **obesity**. This paradigm shift moves beyond traditional sy…
-
Semaglutide, Liraglutide, Tirzepatide Linked to Diverse Cutaneous Adverse Events, Including Injection-Site Reactions and Dysesthesia
A systematic review characterized cutaneous adverse events for semaglutide, liraglutide, and tirzepatide, finding injection-site reactions (tirzepatide 2-7%) and dysesthesia (semaglutide up to 20%) are common.
-
GLP-1 RAs Deliver Attenuated Weight Loss in Breast Cancer Patients on Endocrine Therapy; Semaglutide, Tirzepatide Outperform
GLP-1 RAs achieved only **4.5%** mean weight loss over one year in breast cancer patients on endocrine therapy, significantly less than typical trial results, with semaglutide and tirzepatide performing best.
-
Oral Iron Supplementation at 60 mg/day vs. 30 mg/day to be Assessed for Gestational Diabetes Risk in Non-Anemic Pregnant Women
A large randomized trial will compare 60 mg/day vs. 30 mg/day oral elemental iron in 1600 non-anemic pregnant women to assess gestational diabetes risk and beta-cell function.
-
Berberine local injections improve diabetic foot ulcer healing by **18.7%** post-osteotomy, inhibiting `PDGF-B/PDGFRβ`.
Local berberine injections significantly improved diabetic foot ulcer healing by **18.7%** in patients undergoing tibial osteotomy, reducing inflammation and fibroblast apoptosis.
-
Cardiomyocyte-targeted HSP60 modulates myocardial remodeling and PBMC mitochondrial function in hypertensive diabetic rats
Cardiomyocyte-targeted **HSP60** via AAV9 altered `NLRP3` localization, modulated inflammatory-fibrotic transcripts, and increased PBMC mitochondrial membrane potential in hypertensive diabetic rats.
-
S-ketoprofen stereoselectively interacts with L/D-Trp-Leu-Pro-Phe peptide, influencing aggregation and phototoxicity.
(S)-ketoprofen demonstrates stereoselective interaction with L- and D-enantiomers of the WLPF tetrapeptide, with the D-epimer showing greater aggregation.
-
Engineered Living Vehicles Autonomously Clear MRSA Osteomyelitis, Accelerate Bone Repair in Rats
Engineered Living Vehicles (ELVs) autonomously cleared **MRSA osteomyelitis** and accelerated bone repair in rats by secreting **lysostaphin** and **VIP** via temperature-responsive genetic circuits.
-
Romanian T2DM patients exhibit high residual cardiometabolic risk despite frequent biguanide, SGLT2i, and GLP-1 RA use
Romanian T2DM patients frequently use biguanides (53%), SGLT2 inhibitors (44.8%), and GLP-1 RAs (15.5%), yet exhibit substantial residual cardiometabolic risk.
-
AugACP Framework Achieves 0.9272 F1-Score, Outperforming Baselines in Novel Anticancer Peptide Identification
AugACP, a semi-supervised framework with bio-inspired data augmentation, significantly improves anticancer peptide identification, achieving an F1-score of **0.9272** on novel peptides.
-
Saikosaponin A Accelerates Diabetic Wound Healing by Suppressing Macrophage Pyroptosis and Activating Mitophagy
Saikosaponin A (SSA) accelerated diabetic wound healing by suppressing macrophage pyroptosis and activating AMPK/mitophagy pathways in STZ-induced mice.
-
Case-Based Review Advocates Phenotype-Driven Dyslipidemia Assessment Beyond LDL-C Alone
This review significantly impacts how clinicians and individuals approach dyslipidemia, moving beyond a singular focus on LDL-C. **It emphasizes that a comprehensive assessment integrating advanced lipid markers, metabolic context, and g…
-
Cetylpyridinium Chloride trial initiated to assess sarcopenia prevention in older adults
If this trial demonstrates that Cetylpyridinium Chloride can effectively prevent or slow the progression of sarcopenia, it could represent a significant advancement in geriatric care. **A pharmacological intervention for sarcopenia would…
-
Yijinjing Exercise Trial to Compare Physical Performance Against Resistance Training in Sarcopenic Adults
A 240-participant randomized controlled trial will compare a modified Yijinjing exercise program to resistance training for improving physical performance in adults with sarcopenia.
-
Trial Investigates Concurrent Oxytocin with Foley Bulb for Improved Labor Induction Outcomes
A trial assesses if concurrent oxytocin with Foley bulb for cervical ripening improves labor induction outcomes, including delivery within 24 hours, compared to sequential oxytocin.
-
Optimal Dexmedetomidine Dosing Investigated for Postpartum Cesarean Sedation to Enhance Safety
Optimal **dexmedetomidine** dosing is being investigated for postpartum women during cesarean section to enhance sedation safety and avoid respiratory depression.
-
Tranexamic Acid Prophylaxis Evaluated for Blood Loss in High-Risk Cesarean Delivery
A randomized study investigated tranexamic acid (TXA) prophylaxis to reduce perioperative blood loss in high-risk elective cesarean deliveries.
-
Non-Pharmacological Labour Induction: Membrane Sweeping and Foley Catheter for Women with Prior C-Sections
This paper discusses non-pharmacological labour induction methods, membrane sweeping and transcervical Foley catheter, for women with previous C-sections, noting their safety benefits over prostaglandins.
-
JNJ-64565111 evaluated for safety and efficacy in non-diabetic severely obese participants
If **JNJ-64565111** demonstrates significant efficacy and a favorable safety profile, it could represent a valuable new therapeutic option for individuals living with **severe obesity** who are non-diabetic. **A novel, effective treatmen…
-
Gastric Bypass and Sleeve Gastrectomy Proposed to Outperform Medical Therapy for Type 2 Diabetes
A prospective randomized trial is proposed to compare Roux-en-Y Gastric Bypass and Sleeve Gastrectomy against intensive medical treatment for poorly controlled **Type 2 Diabetes Mellitus**, aiming for superior 36-month glycemic control.
-
Time-Restricted Eating feasible, safe for youth with new-onset Type 1 Diabetes; improves C-peptide, HbA1c in higher BMI subgroup.
Time-Restricted Eating (TRE) is feasible and safe for youth with new-onset Type 1 Diabetes, showing improved C-peptide and HbA1c in those with higher baseline BMI.
-
Ademetionine 1,4-butanedisulfonate plus Dexamethasone significantly enhances therapeutic efficacy in cholestatic hepatitis
Ademetionine 1,4-butanedisulfonate (SAMe-BD) combined with Dexamethasone (DEX) significantly enhanced therapeutic efficacy in cholestatic hepatitis patients, improving liver function, inflammation, and fibrosis markers without increasing…
No loaded studies match that filter. or browse the full 7,730.
Go deeper on one peptide
- Semaglutide662
- Tirzepatide424
- Liraglutide377
- Oxytocin328
- Insulin303
- MGF184
- LL-37101
- Thymosin Alpha-188
- GHRP-682
- Orexin a77
- Epitalon75
- GHK-Cu68
- GHRP-267
- Retatrutide67
- Sermorelin65
- IGF-162
- BPC-15760
- Selank59
- Melanotan II57
- MK-67757
- Semax54
- Cagrilintide53
- PT-14148
- P2147
- SS-3139
- HGH36
- Ipamorelin36
- Hexarelin34
- NAD+33
- MOTS-c32